Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Population-based incidence of human metapneumovirus infection among hospitalized children.

Williams JV, Edwards KM, Weinberg GA, Griffin MR, Hall CB, Zhu Y, Szilagyi PG, Wang CK, Yang CF, Silva D, Ye D, Spaete RR, Crowe JE Jr.

J Infect Dis. 2010 Jun 15;201(12):1890-8. doi: 10.1086/652782.

2.

Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Yang CF, Wang CK, Tollefson SJ, Piyaratna R, Lintao LD, Chu M, Liem A, Mark M, Spaete RR, Crowe JE Jr, Williams JV.

Virol J. 2009 Sep 9;6:138. doi: 10.1186/1743-422X-6-138.

3.

Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.

Tang RS, Spaete RR, Thompson MW, MacPhail M, Guzzetta JM, Ryan PC, Reisinger K, Chandler P, Hilty M, Walker RE, Gomez MM, Losonsky GA.

Vaccine. 2008 Nov 25;26(50):6373-82. doi: 10.1016/j.vaccine.2008.09.018. Epub 2008 Sep 24.

PMID:
18822334
4.

Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials.

Kaur J, Tang RS, Spaete RR, Schickli JH.

J Virol Methods. 2008 Nov;153(2):196-202. doi: 10.1016/j.jviromet.2008.07.012. Epub 2008 Sep 6.

PMID:
18722472
5.

Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters.

Schickli JH, Kaur J, Macphail M, Guzzetta JM, Spaete RR, Tang RS.

Virol J. 2008 Jun 3;5:69. doi: 10.1186/1743-422X-5-69.

6.

A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.

Heineman TC, Schleiss M, Bernstein DI, Spaete RR, Yan L, Duke G, Prichard M, Wang Z, Yan Q, Sharp MA, Klein N, Arvin AM, Kemble G.

J Infect Dis. 2006 May 15;193(10):1350-60. Epub 2006 Apr 12.

PMID:
16619181
7.

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.

Buonagurio DA, Bechert TM, Yang CF, Shutyak L, D'Arco GA, Kazachkov Y, Wang HP, Rojas EA, O'Neill RE, Spaete RR, Coelingh KL, Zamb TJ, Sidhu MS, Udem SA.

Vaccine. 2006 Mar 15;24(12):2151-60. Epub 2005 Nov 21.

PMID:
16413951
8.

The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience.

Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Heck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF, Crowe JE Jr.

J Infect Dis. 2006 Feb 1;193(3):387-95. Epub 2005 Dec 30.

10.

Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.

Prichard MN, Kaiwar R, Jackman WT, Quenelle DC, Collins DJ, Kern ER, Kemble GM, Spaete RR.

Vaccine. 2005 Nov 16;23(46-47):5424-31. Epub 2005 Mar 19.

11.

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.

Tang RS, Mahmood K, Macphail M, Guzzetta JM, Haller AA, Liu H, Kaur J, Lawlor HA, Stillman EA, Schickli JH, Fouchier RA, Osterhaus AD, Spaete RR.

Vaccine. 2005 Feb 25;23(14):1657-67.

PMID:
15705469
12.

Human cytomegalovirus plasmid-based amplicon vector system for gene therapy.

Mahmood K, Prichard MN, Duke GM, Kemble GW, Spaete RR.

Genet Vaccines Ther. 2005 Jan 26;3(1):1.

13.

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.

Tang RS, MacPhail M, Schickli JH, Kaur J, Robinson CL, Lawlor HA, Guzzetta JM, Spaete RR, Haller AA.

J Virol. 2004 Oct;78(20):11198-207.

14.

Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA.

Herfst S, de Graaf M, Schickli JH, Tang RS, Kaur J, Yang CF, Spaete RR, Haller AA, van den Hoogen BG, Osterhaus AD, Fouchier RA.

J Virol. 2004 Aug;78(15):8264-70.

15.

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design.

MacPhail M, Schickli JH, Tang RS, Kaur J, Robinson C, Fouchier RA, Osterhaus AD, Spaete RR, Haller AA.

J Gen Virol. 2004 Jun;85(Pt 6):1655-63.

PMID:
15166450
16.

A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.

Prichard MN, Penfold ME, Duke GM, Spaete RR, Kemble GW.

Rev Med Virol. 2001 May-Jun;11(3):191-200. Review.

PMID:
11376481
17.

Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.

Kemble GW, Annunziato P, Lungu O, Winter RE, Cha TA, Silverstein SJ, Spaete RR.

J Virol. 2000 Dec;74(23):11311-21.

18.

Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine.

Jackman WT, Mann KA, Hoffmann HJ, Spaete RR.

Vaccine. 1999 Feb 26;17(7-8):660-8.

PMID:
10067671
19.

Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs.

Spector FC, Kern ER, Palmer J, Kaiwar R, Cha TA, Brown P, Spaete RR.

J Infect Dis. 1998 May;177(5):1143-54.

PMID:
9592996
20.

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR.

J Virol. 1996 Jan;70(1):78-83.

21.

Human cytomegalovirus structural proteins.

Spaete RR, Gehrz RC, Landini MP.

J Gen Virol. 1994 Dec;75 ( Pt 12):3287-308. Review. No abstract available.

PMID:
7527833
23.

Primary chimpanzee skin fibroblast cells are fully permissive for human cytomegalovirus replication.

Perot K, Walker CM, Spaete RR.

J Gen Virol. 1992 Dec;73 ( Pt 12):3281-4.

PMID:
1335029
25.

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells.

Spaete RR, Alexander D, Rugroden ME, Choo QL, Berger K, Crawford K, Kuo C, Leng S, Lee C, Ralston R, et al.

Virology. 1992 Jun;188(2):819-30.

PMID:
1316682
26.

A recombinant subunit vaccine approach to HCMV vaccine development.

Spaete RR.

Transplant Proc. 1991 Jun;23(3 Suppl 3):90-6. Review. No abstract available.

PMID:
1648843
27.

Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne.

Spaete RR, Saxena A, Scott PI, Song GJ, Probert WS, Britt WJ, Gibson W, Rasmussen L, Pachl C.

J Virol. 1990 Jun;64(6):2922-31.

28.

The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86.

Pachl C, Probert WS, Hermsen KM, Masiarz FR, Rasmussen L, Merigan TC, Spaete RR.

Virology. 1989 Apr;169(2):418-26.

PMID:
2539698
29.

Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.

Spaete RR, Thayer RM, Probert WS, Masiarz FR, Chamberlain SH, Rasmussen L, Merigan TC, Pachl C.

Virology. 1988 Nov;167(1):207-25.

PMID:
2460994
30.

Insertion and deletion mutagenesis of the human cytomegalovirus genome.

Spaete RR, Mocarski ES.

Proc Natl Acad Sci U S A. 1987 Oct;84(20):7213-7.

31.

Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain).

Mocarski ES, Liu AC, Spaete RR.

J Gen Virol. 1987 Aug;68 ( Pt 8):2223-30.

PMID:
3039048
32.

A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class.

Geballe AP, Spaete RR, Mocarski ES.

Cell. 1986 Sep 12;46(6):865-72.

PMID:
3019554
35.

The herpes simplex virus amplicon: analyses of cis-acting replication functions.

Spaete RR, Frenkel N.

Proc Natl Acad Sci U S A. 1985 Feb;82(3):694-8.

36.

Supplemental Content

Loading ...
Support Center